Microarray testing can detect more fetal abnormalities

12/5/2012 | Bloomberg

Chromosomal microarrays spotted more fetal abnormalities than current prenatal tests called karyotypes, according to two studies published in the New England Journal of Medicine. One study showed that microarray testing was just as effective as karyotyping in detecting genetic changes linked to birth defects. In the second study, microarrays helped identify the cause of stillbirth in 87% of the cases, compared with 71% with conventional testing.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ